Therefore, these findings suggest that targeting the LMNA signaling pathway in MDA-MB-231 cells or the AMBRA1 signaling pathway in MCF-7 cells might improve the efficacy of breast cancer targeted treatment. This evidence concerns the gene AMBRA1 and breast cancer.